Free Trial

California Public Employees Retirement System Acquires 19,331 Shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Ryan Specialty logo with Finance background
Remove Ads

California Public Employees Retirement System lifted its position in Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 4.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 482,359 shares of the company's stock after purchasing an additional 19,331 shares during the quarter. California Public Employees Retirement System owned 0.18% of Ryan Specialty worth $30,948,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Rakuten Securities Inc. acquired a new stake in shares of Ryan Specialty in the 4th quarter valued at $27,000. Principal Securities Inc. boosted its holdings in Ryan Specialty by 164.7% in the fourth quarter. Principal Securities Inc. now owns 667 shares of the company's stock valued at $43,000 after acquiring an additional 415 shares during the last quarter. Quarry LP boosted its stake in shares of Ryan Specialty by 109.3% in the 3rd quarter. Quarry LP now owns 808 shares of the company's stock valued at $54,000 after purchasing an additional 422 shares during the last quarter. Harvest Fund Management Co. Ltd acquired a new stake in Ryan Specialty during the 4th quarter worth $54,000. Finally, R Squared Ltd acquired a new stake in shares of Ryan Specialty during the fourth quarter worth $92,000. 84.82% of the stock is owned by institutional investors.

Ryan Specialty Stock Performance

Ryan Specialty stock traded down $2.04 during midday trading on Monday, hitting $68.47. The company's stock had a trading volume of 1,917,025 shares, compared to its average volume of 936,052. The company has a 50-day moving average price of $69.67 and a two-hundred day moving average price of $68.72. Ryan Specialty Holdings, Inc. has a 1-year low of $48.48 and a 1-year high of $77.16. The company has a market cap of $17.93 billion, a price-to-earnings ratio of 99.23, a PEG ratio of 1.19 and a beta of 0.66. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01.

Remove Ads

Ryan Specialty (NYSE:RYAN - Get Free Report) last released its earnings results on Thursday, February 20th. The company reported $0.45 earnings per share for the quarter, missing analysts' consensus estimates of $0.47 by ($0.02). Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. The company had revenue of $663.53 million for the quarter, compared to the consensus estimate of $658.80 million. As a group, sell-side analysts predict that Ryan Specialty Holdings, Inc. will post 2.29 earnings per share for the current year.

Ryan Specialty Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Tuesday, March 4th were issued a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a dividend yield of 0.70%. The ex-dividend date of this dividend was Tuesday, March 4th. This is an increase from Ryan Specialty's previous quarterly dividend of $0.11. Ryan Specialty's dividend payout ratio (DPR) is currently 69.57%.

Insider Activity at Ryan Specialty

In related news, EVP Brendan Martin Mulshine sold 30,000 shares of the firm's stock in a transaction on Friday, March 14th. The stock was sold at an average price of $69.30, for a total transaction of $2,079,000.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Nicholas Dominic Cortezi sold 35,000 shares of the firm's stock in a transaction dated Wednesday, January 15th. The stock was sold at an average price of $65.99, for a total value of $2,309,650.00. Following the transaction, the director now owns 35,609 shares of the company's stock, valued at $2,349,837.91. This trade represents a 49.57 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 241,360 shares of company stock valued at $16,006,428 over the last ninety days. 11.10% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on RYAN shares. UBS Group upped their target price on shares of Ryan Specialty from $82.00 to $84.00 and gave the company a "buy" rating in a research note on Wednesday, February 26th. Keefe, Bruyette & Woods lowered their price target on shares of Ryan Specialty from $77.00 to $76.00 and set an "outperform" rating on the stock in a research note on Friday, February 21st. Wells Fargo & Company upped their price objective on Ryan Specialty from $64.00 to $69.00 and gave the stock an "equal weight" rating in a research note on Friday, February 21st. Finally, Royal Bank of Canada dropped their target price on shares of Ryan Specialty from $73.00 to $72.00 and set a "sector perform" rating on the stock in a report on Friday, February 21st. One analyst has rated the stock with a sell rating, six have given a hold rating and six have given a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average price target of $75.27.

Read Our Latest Research Report on Ryan Specialty

Ryan Specialty Company Profile

(Free Report)

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

Featured Articles

Institutional Ownership by Quarter for Ryan Specialty (NYSE:RYAN)

Should You Invest $1,000 in Ryan Specialty Right Now?

Before you consider Ryan Specialty, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.

While Ryan Specialty currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

These 3 Dividend Stocks Might Be the Safest Bet Right Now
5 International Stocks to Escape U.S. Market Volatility
MicroStrategy’s Bold Bitcoin Bet: Genius Move or Dangerous Gamble?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads